Benefits foregone: Too much of the wrong and too little of the right

American Journal of Managed Care

Volumn 5, Issue 6 SUPPL., 1999, Pages

  Bloom, Bernard S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HEALTH CARE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH ECONOMICS; PRIORITY JOURNAL; UNITED STATES;

ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; HEALTH CARE RATIONING; HEALTH CARE SECTOR; HEALTH SERVICES MISUSE; HUMANS; PRIMARY HEALTH CARE; UNITED STATES;

EID: 0033053848     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Chassin MR, Kosecoff J, Solomon DH, Brook RH. How coronary angiography is used. Clinical determinants of appropriate~ness. JAMA 1987;258:2543-2547.
2. Bernstein SJ, Kosecoff J, Gray D, Hampton JR, Brook RH. The appropriateness of the use of cardiovascular procedures. British versus U.S. perspectives. Int J Technol Assess Health Care 1993;9:3-10.
3. Winslow CM, Kosecoff JB, Chassin M, Kanouse DE, Brook RH. The appropriateness of performing coronary artery bypass surgery. JAMA 1988;260:505-509.
4. Damoiseaux RA, van Balen FA, Hoes AW, de Melker RA. Antibiotic treatment of acute otitis media in children under two years of age: Evidence based? Br J Gen Pract 1998;48(437):1861-1864.
5. Halpern MT, Palmer CS, Seidlin M. Treatment patterns for otitis externa. J Am Board Fam Pract 1999;12:1-7.
6. Gortmaker SL, Bickford AF, Mathewson HO, Dumbaugh K, Tirrell PC. A successful experiment to reduce unnecessary laboratory use in a community hospital. Med Care 1988;26:631-642.
7. Finkel ML, Finkel DJ. The effect of a second opinion program on hysterectomy performance. Med Care 1990;28:776-783.
8. McCarthy EG, Finkel ML. Second consultants' opinion for elective gynecological surgery. Obstet Gynecol 1980;56:403-410.
9. Graboys TB, Biegelsen B, Lampert S, Blatt CM, Lown B. Results of a second-opinion trial among patients recommended for coronary angiography. JAMA 1992;268:2537-2540.
10. Fendrick AM, Ridker PM, Bloom BS. Improved health benefits of increased and expanded utilization of thrombolytic therapy. Arch Intern Med 1994;154:1605-1609.
11. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;29:673-682.
12. Grupo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardio. Gissi2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1992;339:753-770.
13. Mark DB, Klatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator corn-pared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418-1424.
14. Brophy JM, Joseph L. Placing trials in context using Bayesian analysis: GUSTO revisited by Reverend Bayes. JAMA 1995:273:871-875.
15. Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG, Palmer H. Variation in office-based quality: A claims-based profile of care provided to Medicare patients with diabetes. JAMA 1995;273:1503-1508.
16. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993;22(suppl A):14A-19A.
17. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 1998;351:1451-1467.
18. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388.